The non-orally administered triptans

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Migraine, a condition which afflicts 12% of the population, results in substantial pain, hypersensitivities to normal environmental stimuli, nausea/vomiting, disability and enormous costs on individuals and society [1]. Treatments that rapidly and effectively abort migraine attacks are essential in order to limit this migraine burden. Availability of the triptans was a major breakthrough in this regard. Although the orally administered triptans are often the medications of choice when treating migraine, triptans administered by injection, nasal spray, rectal or transdermal routes have some important advantages over the orally administered triptans (Box 3.1). In this chapter, the advantages and disadvantages of the non-orally administered triptans are discussed (Table 3.1).

Original languageEnglish (US)
Title of host publicationTriptans for Migraine
PublisherFuture Medicine Ltd.
Pages33-41
Number of pages9
ISBN (Print)9781780840666, 9781780841335
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Tryptamines
Migraine Disorders
Nasal Sprays
Nausea
Vomiting
Hypersensitivity
Costs and Cost Analysis
Pain
Injections
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schwedt, T. J. (2012). The non-orally administered triptans. In Triptans for Migraine (pp. 33-41). Future Medicine Ltd.. https://doi.org/10.2217/EBO.11.177

The non-orally administered triptans. / Schwedt, Todd J.

Triptans for Migraine. Future Medicine Ltd., 2012. p. 33-41.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schwedt, TJ 2012, The non-orally administered triptans. in Triptans for Migraine. Future Medicine Ltd., pp. 33-41. https://doi.org/10.2217/EBO.11.177
Schwedt TJ. The non-orally administered triptans. In Triptans for Migraine. Future Medicine Ltd. 2012. p. 33-41 https://doi.org/10.2217/EBO.11.177
Schwedt, Todd J. / The non-orally administered triptans. Triptans for Migraine. Future Medicine Ltd., 2012. pp. 33-41
@inbook{8a9dec45529c413180ec2dee306568f4,
title = "The non-orally administered triptans",
abstract = "Migraine, a condition which afflicts 12{\%} of the population, results in substantial pain, hypersensitivities to normal environmental stimuli, nausea/vomiting, disability and enormous costs on individuals and society [1]. Treatments that rapidly and effectively abort migraine attacks are essential in order to limit this migraine burden. Availability of the triptans was a major breakthrough in this regard. Although the orally administered triptans are often the medications of choice when treating migraine, triptans administered by injection, nasal spray, rectal or transdermal routes have some important advantages over the orally administered triptans (Box 3.1). In this chapter, the advantages and disadvantages of the non-orally administered triptans are discussed (Table 3.1).",
author = "Schwedt, {Todd J}",
year = "2012",
month = "1",
day = "1",
doi = "10.2217/EBO.11.177",
language = "English (US)",
isbn = "9781780840666",
pages = "33--41",
booktitle = "Triptans for Migraine",
publisher = "Future Medicine Ltd.",

}

TY - CHAP

T1 - The non-orally administered triptans

AU - Schwedt, Todd J

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Migraine, a condition which afflicts 12% of the population, results in substantial pain, hypersensitivities to normal environmental stimuli, nausea/vomiting, disability and enormous costs on individuals and society [1]. Treatments that rapidly and effectively abort migraine attacks are essential in order to limit this migraine burden. Availability of the triptans was a major breakthrough in this regard. Although the orally administered triptans are often the medications of choice when treating migraine, triptans administered by injection, nasal spray, rectal or transdermal routes have some important advantages over the orally administered triptans (Box 3.1). In this chapter, the advantages and disadvantages of the non-orally administered triptans are discussed (Table 3.1).

AB - Migraine, a condition which afflicts 12% of the population, results in substantial pain, hypersensitivities to normal environmental stimuli, nausea/vomiting, disability and enormous costs on individuals and society [1]. Treatments that rapidly and effectively abort migraine attacks are essential in order to limit this migraine burden. Availability of the triptans was a major breakthrough in this regard. Although the orally administered triptans are often the medications of choice when treating migraine, triptans administered by injection, nasal spray, rectal or transdermal routes have some important advantages over the orally administered triptans (Box 3.1). In this chapter, the advantages and disadvantages of the non-orally administered triptans are discussed (Table 3.1).

UR - http://www.scopus.com/inward/record.url?scp=84959098007&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959098007&partnerID=8YFLogxK

U2 - 10.2217/EBO.11.177

DO - 10.2217/EBO.11.177

M3 - Chapter

AN - SCOPUS:84959098007

SN - 9781780840666

SN - 9781780841335

SP - 33

EP - 41

BT - Triptans for Migraine

PB - Future Medicine Ltd.

ER -